How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

SN

OOTC:SNNAQ
Get a brief AI stock analysisSaves ~ 15 minutes of your time

SN

Sienna Biopharmaceuticals IncOOTC SNNAQ Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

OOTC - OTC

FAIR VALUE

Is SNNAQ undervalued compared to its fair value?

The fair value of SNNAQ stock is hidden USD. Relative to the market price of 0 USD Sienna Biopharmaceuticals Inc is hidden.

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. The company is headquartered...[More about valuation]

Sienna Biopharmaceuticals Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0 $B

Price:

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.129

FINANCIALS

Sienna Biopharmaceuticals financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0088 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.004 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0.043 B
0.023 B

Financial Position Analysis

Assets

0.043 B
Current Assets
0.02 B
Total non-current assets
0.024 B

Total current liabilities
0.0013 B
Total non-current liabilities
0.019 B

Cash Flow Statement

-N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.018 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Sienna Biopharmaceuticals fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is SNNAQ attractive for investment based on fundamental analysis?

SNNAQ stock rating is hidden. Sienna Biopharmaceuticals is a hidden by Eyestock methodology.

Get SNNAQ Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

SNNAQ analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for SNNAQ to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Sienna Biopharmaceuticals Inc competitors

LL

LLY

Eli Lilly and Co

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs ...

Discover

NO

NOVO B.CO

Novo Nordisk A/S

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged i...

Discover

JN

JNJ

Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. The company is headquartered in Ne...

Discover

Sienna Biopharmaceuticals Inc dividends

SNNAQ dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About SNNAQ stock

About the company Sienna Biopharmaceuticals Inc

Market cap $B

0

Dividend yield

Shares outstanding

30.91 B

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. The company is headquartered in Westlake Village, California and currently employs 13 full-time employees. The company went IPO on 2017-07-27. The firm is focused on developing multi-asset pipeline of topical therapies that enhance the health, appearance of life of dermatology patients. The company also advancing multiple product candidates derived from Topical by Design platform, all of which are designed to be suitable for chronic administration in patients with inflammatory skin diseases and other dermatologic and aesthetic conditions. It's SNA-120 is a first-in-class inhibitor of Tropomyosin receptor kinase A, or TrkA, in Phase IIb clinical development for the treatment of pruritus, or itch, associated with psoriasis, as well as for psoriasis itself. It's SNA-125 is a topical Janus kinase 3 (JAK3)/TrkA inhibitor with the potential to treat various inflammatory conditions, including atopic dermatitis, psoriasis and pruritus. Nonclinical studies have demonstrated anti-inflammatory activity in an animal model, and a favorable safety profile.

SNNAQ profile

  • Ticker

    SNNAQ

  • Country

    USA

  • Exchange

    OOTC - OTC

  • Report currency

    USD - US dollar

  • IPO date

    27 July 2017

  • Sector

    Healthсare

  • Industry

    Pharmaceuticals

  • Employees

    13

  • City

    Westlake Village

  • Address

    30699 Russell Ranch Rd Ste 140

  • Cusip

    82622H108